Xue Hong

1.4k total citations
31 papers, 973 citations indexed

About

Xue Hong is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Xue Hong has authored 31 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 12 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Xue Hong's work include Chronic Kidney Disease and Diabetes (13 papers), Acute Kidney Injury Research (7 papers) and Renal Diseases and Glomerulopathies (6 papers). Xue Hong is often cited by papers focused on Chronic Kidney Disease and Diabetes (13 papers), Acute Kidney Injury Research (7 papers) and Renal Diseases and Glomerulopathies (6 papers). Xue Hong collaborates with scholars based in China, United States and Hong Kong. Xue Hong's co-authors include Youhua Liu, Lili Zhou, Fan Fan Hou, Jinhua Miao, Haiyan Fu, Haili Zhu, Yulin Liao, Yongping Wang, Li Li and Fan Fan Hou and has published in prestigious journals such as Scientific Reports, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Xue Hong

28 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Hong China 17 468 343 158 129 116 31 973
Mark E.C. Dockrell United Kingdom 21 566 1.2× 370 1.1× 130 0.8× 95 0.7× 131 1.1× 49 1.1k
Gaiqin Pei China 12 371 0.8× 222 0.6× 203 1.3× 149 1.2× 67 0.6× 27 900
Dorella Del Prete Italy 21 495 1.1× 452 1.3× 124 0.8× 169 1.3× 258 2.2× 64 1.3k
Zhengzhe Li China 19 471 1.0× 359 1.0× 72 0.5× 97 0.8× 83 0.7× 33 1.1k
Monica Ceol Italy 18 350 0.7× 305 0.9× 62 0.4× 87 0.7× 132 1.1× 41 850
Cristina Alonso‐Montes Spain 15 302 0.6× 365 1.1× 74 0.5× 80 0.6× 126 1.1× 39 851
Guangjie Guo United States 10 604 1.3× 422 1.2× 80 0.5× 124 1.0× 254 2.2× 11 1.1k
Akashi Togawa Japan 16 596 1.3× 356 1.0× 89 0.6× 104 0.8× 129 1.1× 40 1.0k
Ana B. Rodríguez-Peña Spain 15 338 0.7× 321 0.9× 112 0.7× 82 0.6× 153 1.3× 17 807
Yuansheng Xie China 16 292 0.6× 544 1.6× 56 0.4× 149 1.2× 119 1.0× 40 1.1k

Countries citing papers authored by Xue Hong

Since Specialization
Citations

This map shows the geographic impact of Xue Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Hong more than expected).

Fields of papers citing papers by Xue Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Hong. The network helps show where Xue Hong may publish in the future.

Co-authorship network of co-authors of Xue Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Hong. A scholar is included among the top collaborators of Xue Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Hong. Xue Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Qian, Xi Liu, Huishi Tan, et al.. (2025). Matrix metalloproteinase-10 promotes kidney fibrosis by transactivating β-catenin signaling. Cell Death Discovery. 11(1). 241–241. 1 indexed citations
2.
Li, Li, Yuxi Zhang, Junxin Huang, et al.. (2025). Single Cell and Spatial Transcriptomics Define a Proinflammatory and Profibrotic Niche After Kidney Injury. Advanced Science. 13(2). e03691–e03691.
3.
Hong, Xue, et al.. (2024). Chronic alcohol consumption aggravates acute kidney injury through integrin β1/JNK signaling. Redox Biology. 77. 103386–103386. 4 indexed citations
4.
Hong, Xue, et al.. (2024). m6A RNA methylation drives kidney fibrosis by upregulating β-catenin signaling. International Journal of Biological Sciences. 20(8). 3185–3200. 7 indexed citations
6.
Zhou, Jiayi, et al.. (2023). Limonin mitigates cisplatin-induced acute kidney injury through metabolic reprogramming. Biomedicine & Pharmacotherapy. 167. 115531–115531. 6 indexed citations
7.
Hong, Xue, Yuan Gui, Wenjian Min, et al.. (2023). Limonin, a natural ERK2 agonist, protects against ischemic acute kidney injury. International Journal of Biological Sciences. 19(9). 2860–2878. 11 indexed citations
8.
Li, Li, Meizhi He, Junxin Huang, et al.. (2023). Proteomic landscape of the extracellular matrix in the fibrotic kidney. Kidney International. 103(6). 1063–1076. 33 indexed citations
9.
Li, Li, Huishi Tan, Haili Zhu, et al.. (2022). Insulin-like growth factor 2 mRNA-binding protein 3 promotes kidney injury by regulating β-catenin signaling. JCI Insight. 8(2). 15 indexed citations
10.
Chen, Xiaowen, Huishi Tan, Jie Xu, et al.. (2022). Klotho-derived peptide 6 ameliorates diabetic kidney disease by targeting Wnt/β-catenin signaling. Kidney International. 102(3). 506–520. 57 indexed citations
11.
Wang, Chunhong, Jiafeng Liu, Xiaoyao Zhang, et al.. (2022). Role of miRNA-671-5p in Mediating Wnt/β-Catenin-Triggered Podocyte Injury. Frontiers in Pharmacology. 12. 784489–784489. 9 indexed citations
12.
Ren, Qian, Shan Zhou, Xue Hong, et al.. (2021). Matrix metalloproteinase-10 protects against acute kidney injury by augmenting epidermal growth factor receptor signaling. Cell Death and Disease. 12(1). 70–70. 25 indexed citations
13.
Li, Li, Qian Yuan, Xue Hong, et al.. (2021). Fibrillin-1–enriched microenvironment drives endothelial injury and vascular rarefaction in chronic kidney disease. Science Advances. 7(5). 47 indexed citations
14.
Wang, Cong, Jixing Liu, Xue Hong, et al.. (2021). Identification of matrix metalloproteinase-10 as a key mediator of podocyte injury and proteinuria. Kidney International. 100(4). 837–849. 26 indexed citations
15.
Zhu, Haili, et al.. (2020). Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via αvβ6 integrin signaling. Kidney International. 97(5). 1017–1031. 63 indexed citations
16.
Zhao, Shihua, Cong Wang, Xue Hong, et al.. (2019). Wnt/β-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome. Kidney International. 95(4). 815–829. 85 indexed citations
17.
Zhao, Yue, Chunhong Wang, Cong Wang, et al.. (2018). An essential role for Wnt/β-catenin signaling in mediating hypertensive heart disease. Scientific Reports. 8(1). 8996–8996. 81 indexed citations
18.
Ning, Hailong, et al.. (2017). Mapping stable QTLs for growth period procedure based on four-way recombination inbred line population.. Dadou kexue. 36(5). 692–698. 2 indexed citations
19.
Mo, Hongyan, Qinyu Wu, Jinhua Miao, et al.. (2016). C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury. Antioxidants and Redox Signaling. 27(6). 345–362. 40 indexed citations
20.
Hong, Xue. (2006). Between the Hammer and the Block: China's Intellectual Property Rights in the Network Age. SSRN Electronic Journal. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026